Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Innocan Pharma Corp C.INNO

Alternate Symbol(s):  INNPF

Healthcare
Innocan Pharma Corporation is an Israel-based pharmaceutical company active in the medical cannabis industry. It operates through three distinct operating segments: Research, Development, Marketing, Distribution and sales of InnoCan-branded over the counter (OTC) pharmaceutical products; Research and Development of Non-pharmaceutical products for third parties and Research and Development of... see more

Recent & Breaking News (CSE:INNO)

Innocan Pharma Announces the Publication of Two Studies Supporting Its CLX Therapy for COVID-19 Infected Lung Cells

Newsfile October 23, 2020

Innocan Pharma's Clinical Study in the US Indicates that More than 90% of Participants Experienced Pain Reduction After Using Innocan's Relief &Go OTC Pain Relief Spray

Newsfile October 19, 2020

Innocan Pharma's Cosmetic Clinical Study Indicates a 90% Wrinkle Reduction After Using Its SHIR(TM) Premium CBD Facial Serum

Newsfile October 15, 2020

Innocan Achieves Major Milestone in Developing Its Unique CBD-Loaded Liposome Platform Technology for Injectable CBD

Newsfile October 9, 2020

Innocan Pharma to Provide a Corporate Update via Livestream Video

Newsfile October 8, 2020

Innocan Phrama Completes Successful Cosmetic Clinical Studies Demonstrating the Efficacy of Its SHIR(TM) CBD Premium Facial Serum on Skin Hydration

Newsfile September 15, 2020

Innocan Pharma to Amend Warrants Held by Tamar Technologies Ltd.

Newsfile September 14, 2020

Innocan Pharma Announces Publication of Enterprise Report by Mackie Research

Newsfile September 3, 2020

Innocan to Distribute Its CBD Line of Products in Italy and Switzerland

Newsfile August 20, 2020

Innocan Engages Endless Sky to Manufacture and Distribute Innocan's CBD Cosmetic Products in Canada

Newsfile August 11, 2020

Innocan's SHIR (TM) Beauty & Science CBD Derma Cosmetics Products Passed Safety Assessments and Have Been Approved for Marketing in the European Union

Newsfile August 6, 2020

Innocan's Over-The-Counter Pain Relief Spray Receives FDA's Technical Validation for Marketing in the USA

Newsfile July 13, 2020

InnoCan Pharma Collaborate with Recipharm on its CBD Loaded Exosome (CLX) Treatments

Newsfile July 9, 2020

Innocan Pharma's Corporate Update

Newsfile July 2, 2020

InnoCan Pharma Announces the Successful Completion of an Independent Clinical Study Demonstrating Safety and Skin Tolerance of Its CBD Derma Cosmetic Line

Newsfile June 26, 2020

Innocan Pharma Announces Mackie Research's Institutional Sales Group Issues Enterprise Publication on the Company

Newsfile June 22, 2020

InnoCan Signs Letter of Intent with Tamar to Distribute and Supply CBD "API" for use in InnoCan's Research Projects

Newsfile June 17, 2020

Innocan Pharma Announces Closing of $5.1 Million Prospectus Offering of Units

Newsfile June 10, 2020

InnoCan Pharma Announced the Commencement of its Derma CBD Line Commercial Production in Portugal

Newsfile June 5, 2020

Innocan Pharma Amends Terms of Marketed Short Form Prospectus Offering of Units

Newsfile June 2, 2020